Research Roundup: Lassa vaccine trial, Visceral leishmaniasis project, WHO PQ for HIV test
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
GHTC welcomes the World Health Organization's (WHO's) newly announced plans to parallel the processes of prequalification and/or Emergency Use Listing assessments and recommendations on product use to expedite access to health products.
Months of tense congressional negotiations stretching nearly six months over schedule finally concluded with the signing of a FY24 spending package in the same month President Joe Biden released his budget proposal for FY25. GHTC breaks down what this all means for global health R&D.